ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 346098 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 346098; 2) Community: the network communities that were significantly associated with the response to NSC 346098; 3) Molecule: the relationships between components within communities and NSC 346098; 4) MDR: the compounds that were significantly associated with the NSC 346098.

NSC Compound Enrichment Correlation
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.013789112253851 0.073337557
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.013789112253851 0.054974867
NSC 278632 Null 0.0171490505199911 0.22362169
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0171490505199911 0.28289673
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0171490505199911 0.34207926
NSC 645317 Sanguilutine pseudobase 0.0171490505199911 0.38116877
NSC 666496 Null 0.0171490505199911 0.68316808
NSC 672131 Null 0.0171490505199911 0.33307322
NSC 67799 Pyrimidine, 2,4,6-trichloro-5-ethyl- 0.0171490505199911 0.26383923
NSC 702134 Null 0.0171490505199911 0.50320855
Total:77  Current:33    [First] [Prev] [Next] [Last]